United Kingdom

People: Amedisys Inc (AMED.OQ)

AMED.OQ on NASDAQ Stock Exchange Global Select Market

17 Sep 2019
Change (% chg)

$1.45 (+1.11%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Klapstein, Julie 

Ms. Julie D. Klapstein is Independent Director of Amedisys, Inc. Ms. Klapstein was the founding Chief Executive Officer of Availity, LLC, one of the nation’s largest health information networks optimizing the automated delivery of critical business and clinical information among healthcare stakeholders. Ms. Klapstein was the Chief Executive Officer and board member of Availity for 11 years. Ms. Klapstein’s 30+ years of experience in the healthcare information technology industry include executive roles at Phycom, Inc. as Chief Executive Officer, Sunquest Information Systems (EVP); SMS’ Turnkey Systems Division (now Siemens Medical Systems) and GTE Health Systems. She currently serves on the board of directors for Quality Systems, Inc., a firm that provides software and services to medical and dental offices, eSolutions, Inc., specializing, in revenue cycle management solutions, Dominion Diagnostics, LLC, a firm specializing in laboratory services, Bottom Line Systems, a firm specializing in underpayment and denial for hospitalization, and the Grand Canyon Association, the official nonprofit partner of the Grand Canyon National Park. Ms. Klapstein was a past director for two public boards: Annies, Inc. and Standard Register and has been a director for multiple private companies. Ms. Klapstein earned her bachelor’s degree from Portland State University in Portland, Oregon. She is the recipient of multiple awards for top business leadership.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 150,032
Long-Term Incentive Plans, USD --
All Other, USD 109,000
Fiscal Year Total, USD 259,032

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Donald Washburn


Paul Kusserow


Scott Ginn


Christopher Gerard


Sharon Brunecz


Michael North

As Of  31 Dec 2018